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Case Report
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Primary urethral carcinoma (UC) is considered to be rare cancer, accounting for <1% of all malignancies [1]. Carcinomas of the bulbomembranous urethra are of 
squamous cell origin in 80%, transitional cell origin in 10%, 
and adenocarcinoma or undifferentiated in 10% [2]. At initial 
presentation visible hematuria or bloody urethral discharge is 
reported in up to 62% of the cases, however, symptoms of locally 
advanced disease include an extra urethral mass (52%), bladder 
outlet obstruction (48%), pelvic pain (33%), urethrocutaneous 
fistula (10%), abscess formation (5%), or dyspareunia [3]. Here, 
we present a case of a primary bulbar UC of transitional cell 
origin which presented as a scrotal abscess subsequently causing 
a diagnostic dilemma.
CASE REPORT
A 66-year-old man presented to the emergency surgical department 
with swelling, pain, and pus discharge from the scrotum in midline 
since 5 days. The patient underwent an incision and drainage on 
clinical suspicion and urethra was breached during the procedure. 
Suprapubic cystostomy (SPC) and biopsy from the suspicious 
region were taken. Histopathology was suggestive of infiltrating 
transitional cell carcinoma of urethra (Fig. 1). On further 
questioning, the patient revealed the history of voiding lower 
urinary tract symptoms and per urethral bleeding on and off. The 
patient was a known case of diabetes mellitus and hypertension 
from 5 years. He was a chronic smoker from past 25 years.
General physical examination of the patient was unremarkable. 
On local examination, external urethral meatus was narrow; 
urethrocutaneous fistula was present at the scrotum in midline 
with pus discharge and induration along the previous incision 
(Fig. 2). Inguinal lymph nodes were not palpable. Digital 
rectal examination was within normal limits. Routine blood 
investigations were within normal limits except total leukocyte 
count which was 13,000 and serum creatinine which was 
2.4 mg/dl initially but later decreased to 1.2 mg/dl 2 weeks after 
SPC. The patient presented to us with a pre-operative retrograde 
urethrogram (Fig. 3a) and micturating cystourethrogram (Fig. 3b) 
which was suggestive of a long stricture of the penile urethra with 
extravasation of contrast at bulbar urethra into a large collection 
in the scrotum and diverticula in the urinary bladder. The posterior 
urethra was normal.
A contrast enhanced computed tomography was done to 
evaluate the upper urinary tract, chest, and abdomen which were 
normal. Antegrade cystoscopy of the patient revealed a normal 
posterior urethra. To further characterize the lesion, magnetic 
resonance imaging (MRI) of pelvis was done which revealed 
a large space occupying lesion (56 mm × 51 mm × 64 mm) in 
bulbar part of urethra involving corporal bodies without lymph 
node enlargement (Fig. 4). Total penectomy with anterior 
urethrectomy with left orchiectomy was done. Intraoperatively, 
the growth was found confined to bulbar urethra. Posterior urethra 
was found to be normal. Prostatomembranous junction was taken 
as the posterior margin. Left scrotum found to be indurated. The 
specimen was sent for histopathology. The patient was stable in 
the post-operative period and was discharged with SPC in situ. 
On histopathology, microscopy suggested invasive urothelial 
carcinoma. All the margins were free from tumor. The patient is 
in close follow-up in the department of urology as well as medical 
oncology. A follow-up ultrasonography of whole abdomen was 
done which revealed mild prostatomegaly and no evidence of any 
lymph nodes.
ABSTRACT
Primary urethral carcinoma (UC) is a rare entity, and bulbar UCs of transitional cell origin are even rarer. Primary presentation as a 
scrotal abscess and urethrocutaneous fistula is rarely documented in UC patients. We present a case of a 66-year-old male presenting 
to emergency department with a scrotal abscess. Following blind incision and drainage, the urethral injury was suspected, and 
biopsy of suspicious lesion was taken from scrotum which came out to be invasive transitional cell carcinoma. A wide local excision 
of the tumor was done after workup. Hence, all patients with scrotal abscess and urethrocutaneous fistula should be investigated 
before performing any blind procedure.
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Fig. 1 Disorganised papillae showing high grade nuclear features 
(H and E original magnification 100×) Inset: (400× magnification). 
Nuclear pleomorphism with clumped chromatin, prominent nucleoli, 
and irregular nuclear membranes
Fig. 3: (a) Retrograde urethrogram showing long stricture of the 
penile urethra with extravasation of contrast (arrow) into a large 
collection in the scrotum. (b) Micturating cystourethrogram showing 
obstructive changes with diverticula (arrow head) in the urinary 
bladder and normal posterior urethra (arrow)
a b
Fig. 4: A large mass (56 mm × 51 mm × 64 mm) seen in bulbar part of 
urethra (arrow) involving corpora cavernosa and spongiosa 
Fig. 2 Local Examination showing urethra-cutaneous fistula and pus 
discharge.
DISCUSSION
Primary UC is considered to be a rare cancer. According to 
surveillance, epidemiology, and end results database, the incidence of 
primary UC was majorly in the 75 years and above age group [4]. For 
male primary UC, various predisposing factors have been reported, 
including urethral strictures, chronic irritation after intermittent 
catheterization, urethroplasty, radiation therapy, and chronic urethral 
inflammation following sexually transmitted diseases. In female UC, 
urethral diverticula and recurrent urinary tract infections have been 
associated with primary UC [5]. The bulbomembranous urethra is 
involved most frequently, accounting for 60% of tumors, followed 
by the penile urethra (30%) and prostatic urethra (10%).
The histologic subtype of urethral cancer varies by anatomic 
location. Carcinomas of the prostatic urethra are of transitional cell 
origin in 90% and squamous cell origin in 10%; carcinomas of the 
penile urethra are of squamous cell origin in 90% and transitional 
cell origin in 10%; carcinomas of the bulbomembranous urethra 
are of squamous cell origin in 80%, transitional cell origin in 
10%, and adenocarcinoma or undifferentiated in 10%. Hematuria 
or bloody urethral discharge is reported in up to 62% of the cases. 
Symptoms of locally advanced disease include extra urethral 
mass (52%), bladder outlet obstruction (48%), pelvic pain (33%), 
urethrocutaneous fistula (10%), and abscess formation (5%) [3].
For local staging and monitoring tumor response to 
neoadjuvant chemoradiotherapy, MRI is an accurate tool before 
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surgery [6]. CT of the thorax and abdomen should be considered 
for metastatic workup in all patients with invasive disease [7]. 
Prophylactic bilateral inguinal and/or pelvic lymphadenectomy is 
still under scrutiny. However, in patients with clinically enlarged 
inguinal/pelvic lymph nodes or invasive tumors, regional 
lymphadenectomy should be considered for initial treatment 
in limited disease [8]. Partial penectomy with a 2-cm negative 
margin remains the traditional treatment for tumors infiltrating 
the corpus spongiosum and localized to the distal half of the 
penis. Excellent local control after this procedure has been 
documented [9]. If invasive disease extends to or involves the 
proximal penile urethra, total penectomy is required to obtain an 
adequate margin of excision.
A local recurrence rate of 13% has been reported after this 
procedure. Primary radiation therapy has been reserved for 
patients, which presents with early stage lesions of the anterior 
urethra and refuses surgery. Chemoradiation with mitomycin-c 
and 5-FU along with concurrent external beam radiation 
therapy has been reported as a treatment modality for patients 
with invasive anterior urethral cancer with the intent of genital 
preservation [10]. Further studies are needed to validate this 
modality.
CONCLUSION
Primary UC is a rare entity. Although rare, a patient presenting 
with scrotal abscess and urethra-cutaneous fistula may harbour 
a urethral carcinoma underneath and cause diagnostic dilemma.
Therefore, adequate imaging should be considered before any 
surgical procedure. Given the low incidence of primary urethral 
cancer, follow-up has not been investigated systematically so far. 
Urinary cytology, urethrocystoscopy, and cross-sectional imaging 
should be considered despite the lack of sufficient data.
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